TRVI — Trevi Therapeutics Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Trevi Therapeutics Inc (TRVI), worth $57.80M combined. Over the quarter 0 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Emerald | $33.53M | 0.79% | -2.3% |
| Emerald Mutual | $22.58M | 0.79% | -4.1% |
| BIT | $839.25K | 0.03% | NO CHANGE |
| Persistent | $477.46K | 0.15% | -8.3% |
| Chapin Davis | $374.87K | 0.07% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.